Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:e10

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, H.-M.
Right arrow Articles by Sam, C.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, H.-M.
Right arrow Articles by Sam, C.-K.

(Hypertension. 1999;34:e10.)
© 1999 American Heart Association, Inc.


Letters to the Editor - Web

Regulatory Natural Antibodies in Hypertension?

Hwee-Ming Cheng; Shabana Aafaqi; Choon-Kook Sam

Department of Physiology, Institute of Postgraduate Studies, Universiti Malaya, Lumpur, Malaysia


*    Introduction
 
To the Editor:

We read with interest the recent report by Wu et al1 on the reduction of both IgG and IgM autoantibodies to oxidized LDL (OxLDL) in individuals with borderline hypertension compared with normotensive controls. We would like to extend the implication of their data with results from our own studies of natural antibodies in healthy persons.

We recently detected in all normal human serum (NHS), natural antibodies to oxysterols (including cholesterol epoxide, 7keto-, 19hydroxy-, and 7hydroxy- cholesterol), which are main components of LDL that have undergone oxidative modification.2 The consistent presence of anti-oxysterol (and by extension, anti-OxLDL) was postulated to be important in regulating the concentration and bioactivity of OxLDL (which comes from either a dietary source or from in vivo oxidation3 ), which is thought to be involved in endothelial dysfunction and other events in the atherogenic process. The lowered serum anti-OxLDL in Wu et al’s study might therefore be related to this suggestion.

An additional role of natural antibodies in regulating blood pressure is also indicated by the finding of natural antibodies that recognize renin, angiotensin II, and catecholamines.4 5 6 Diet appears to influence this natural humoral immunoreactivity. We have also observed autoantibodies to aldosterone in normal subjects. In an ELISA system, all eleven NHS that were tested contained specific IgG and IgA, and 8 of the 11 sera also had IgM antialdosterone antibodies (S.A. et al, unpublished data, 1999).

Natural antibodies are thought to function as immunotransporters in addition to being involved in the physiological clearance . . . [Full Text of this Article]